comparemela.com
Home
Live Updates
Unveil Favorable Findings - Breaking News
Pages:
Latest Breaking News On - Unveil favorable findings - Page 1 : comparemela.com
Encouraging Results Emerge from Phase 1/2 Study of mRNA-Based Influenza and COVID-19 Combo Vaccines
This combination vaccine candidate, with a safety profile consistent with Pfizer’s COVID-19 vaccine, will most likely be moving to a phase 3 trial in the coming months.
Annaliesa-anderson
Pfizer
Combo-vaccine-program-targeting-influenza
Head-of-vaccine-research
Contemporary-pediatrics
Geometric-mean-titer
Senior-vice-president
Vaccine-research
Fast-track-designation
Unveil-favorable-findings
Based-combo-vaccine-program-targeting-influenza
Influenza
vimarsana © 2020. All Rights Reserved.